UVEAL MELANOMA, METASTATIC
Clinical trials for UVEAL MELANOMA, METASTATIC explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA, METASTATIC trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New capsule aims to fight rare eye cancer that spreads
Disease control Recruiting nowThis study tests an experimental drug called NBM-BMX in people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. The goal is to find the best dose, check for side effects, and see if the drug can shrink or slow tumors. Participants take…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Jun 23, 2026 23:47 UTC
-
New combo therapy aims to boost immune attack on eye cancer
Disease control Recruiting nowThis early-stage trial tests whether adding a new drug called roginolisib to the existing treatment tebentafusp can help people with advanced uveal melanoma, a rare eye cancer. The study involves 8 adults whose cancer has spread and who are already on tebentafusp. The main goal i…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 23, 2026 11:54 UTC
-
New drug MBS8 tested in patients with advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called MBS8(1V270) in about 106 adults with advanced solid tumors that have worsened despite other treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. Participants must have a tumor th…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: MonTa Biosciences ApS • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC
-
New radioactive drug targets tough melanoma
Disease control Recruiting nowThis early-stage trial tests an investigational drug for adults with melanoma that has spread or cannot be surgically removed. The main goals are to find the safest dose and understand side effects. Participants receive the drug once every 6 weeks for up to 6 doses, with regular …
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC